Back to News
Market Impact: 0.25

SpaceX Investors Who Bought After the IPO Have Watched Their Gains Nearly Disappear. What Should They Do Now?

IPOs & SPACsCompany FundamentalsMarket Technicals & FlowsInvestor Sentiment & PositioningTechnology & InnovationArtificial Intelligence
SpaceX Investors Who Bought After the IPO Have Watched Their Gains Nearly Disappear. What Should They Do Now?

SpaceX is trading below its IPO price despite still being valued at over $2 trillion, or roughly the world's seventh-most-valuable public company. The article warns that historical post-IPO patterns suggest underperformance and says investors should wait until well after lock-up periods before considering an entry. It also notes the company lost nearly $5 billion in 2025 and trades at well over 100x sales, implying elevated valuation risk.

Analysis

The market is treating this IPO like a sentiment trade, but the more important setup is supply overhang versus forced-duration demand. Early post-listing weakness usually reflects insiders and pre-IPO holders monetizing while new public investors are still anchoring to scarcity and narrative; that combination can suppress price for months even if the business quality is exceptional. In that window, the stock can remain “expensive on fundamentals” yet still cheap versus its own future optionality, which is why the right question is not whether the company is good, but whether the float is absorbable at this valuation.

The second-order issue is that the listed equity may become a proxy for a basket of adjacent winners, not just a direct bet on the company itself. If space launch cadence, satellite connectivity, AI infrastructure, and off-planet data-center ambitions keep attracting capital, the cleanest public-market expression is likely in semis, cloud, and AI infrastructure beneficiaries with immediate cash flow rather than the newly listed name with multi-year execution risk. That favors the familiar megacap ecosystem over a high-duration single-name story where any operational miss can compress the multiple sharply.

The contrarian angle is that near-term underperformance may be less about business skepticism and more about mechanical post-IPO digestion. If lockups unlock into a market that already owns too much narrative exposure, the stock could see another leg lower even without fundamental deterioration. Conversely, a sustained base after lockup expiry would be a stronger signal than the IPO tape, because it would indicate real fundamental sponsorship rather than pure speculation.

For now, the setup argues for patience, not conviction buying. The risk/reward improves only after supply pressure clears and the stock has time to reprice on actual operating metrics rather than story-premium momentum.

More News